Targeted News Service logo

-- Preview Email Newsletter
Reports from Public Policy Newsletter for 2025-05-30 ( 7 items )  
Analysis Exposes Destruction in France's Most Iconic Marine Protected Areas as Nation Prepares to Host 3rd United Nations Ocean Conference (10)
WASHINGTON, May 29 (TNSrpt) -- Oceana, an international advocacy organization dedicated solely to ocean conservation, issued the following news release: * * * New Analysis Exposes Destruction in France's Most Iconic Marine Protected Areas as Nation Prepares to Host 3rd United Nations Ocean Conference Oceana uncovers over 17,000 hours of destructive fishing inside France's Marine Nature Parks, Calls on President Macron to ban bottom trawling in protected areas Nice, France. Just before Franc more PR

E2: $14 Billion in Clean Energy Projects, 10,000 Jobs Cancelled So Far in 2025; $4.5 Billion Cancelled in April (10)
WASHINGTON, May 30 (TNSrep) -- Environmental Entrepreneurs issued the following news release: * * * E2: $14 Billion in Clean Energy Projects, 10,000 Jobs Cancelled So Far in 2025; $4.5 Billion Cancelled in April * Business uncertainty taking toll on clean energy industry jobs, investments as Congress moves to raise taxes on industry * 10,000 new jobs cancelled since January alone; more losses expected if Senate approves "One Big Beautiful Bill Act" * $486 million in new investments announce more PR

ICYMI: New Accountable.US Report Reveals Trump Judicial Nominees are at the Center of Reviving the Crusade to Ban Medication Abortion (10)
WASHINGTON, May 29 [Category: Government/Public Administration] (TNSrep) -- Accountable.US, an organization that says it conduct investigations to expose conflicts of interest, issued the following news release: * * * ICYMI: New Accountable.US Report Reveals Trump Judicial Nominees are at the Center of Reviving the Crusade to Ban Medication Abortion WASHINGTON, DC - In case you missed it, an Accountable.US report (https://accountable.us/wp-content/uploads/2025/05/20250519-A.US-Trump-Nominees- more PR

Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Secondary Progressive Multiple Sclerosis (10)
BOSTON, Massachusetts, May 30 (TNSrpt) -- The Institute for Clinical and Economic Review issued the following news release on May 29, 2025: * * * Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Secondary Progressive Multiple Sclerosis There are significant uncertainties regarding long term efficacy of tolebrutinib; ICER estimates that treatment would achieve common thresholds of cost-effectiveness if priced between $3,250 and $5,900 per year BOSTON, May  more PR

ISTH Annual Report Showcases 2024 Global Impact and Innovation (10)
CARRBORO, North Carolina, May 30 (TNSrpt) -- The International Society for Thrombosis and Haemostasis issued the following news: * * * ISTH Annual Report showcases 2024 global impact and innovation The International Society on Thrombosis and Haemostasis (ISTH) announces the publication of its 2024 Annual Report, now available for download. The ISTH Annual Report showcases the Society's continued commitment to advancing the understanding, prevention, diagnosis and treatment of thrombosis and  more PR

Rushed Privatization of Fannie and Freddie Could Raise Mortgage Costs and Destabilize Housing Market, New Brief Reveals (10)
WASHINGTON, May 29 [Category: Sociological] (TNSrpt) -- The American Economic Liberties Project posted the following news release: * * * Rushed Privatization of Fannie and Freddie Could Raise Mortgage Costs and Destabilize Housing Market, New Brief Reveals Washington, D.C. -- In the wake of President Trump's comments stating he is giving "serious consideration" to ending the 17 year conservatorship of Fannie Mae and Freddie Mac, American Economic Liberties Project released a new policy brief  more PR

Scripps Research Institute: AI Pinpoints New Anti-aging Drug Candidates (10)
LA JOLLA, California, May 30 (TNSrpt) -- The Scripps Research Institute issued the following news: * * * AI pinpoints new anti-aging drug candidates More than 70% of the drugs identified by artificial intelligence extended the lifespan of C. elegans worms. LA JOLLA, CA--Everyone wants to slow down aging--but despite decades of research, truly effective anti-aging drugs remain elusive. Most drug discovery efforts for aging have focused on targeting single biological pathways, an approach that more PR